[Results of ARMYDA-ACS trial show good outcome of 80 mg atorvastatin pretreatment in patients with acute coronary syndromes undergoing early percutaneous coronary intervention].
Michałek
Aleksandra
A
Miedzyleski Szpital Specjalistyczny, Warsaw.
D054058:Acute Coronary Syndrome / Q000188:drug therapy / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D000924:Anticholesteremic Agents / Q000008:administration & dosage*; D000069059:Atorvastatin; D006538:Heptanoic Acids / Q000008:administration & dosage*; D006801:Humans; D011758:Pyrroles / Q000008:administration & dosage*; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin